Dompé

Major Drugs - Milano, Lombardia, IT

Dompé Employees
Eric Jordan

Senior Director, Marketing

Contact Eric Jordan

Walter Vassillo

Manufacturing Science and Technology (MSAT) and PMO Associate Director

Contact Walter Vassillo

Nancy Reyes

Medical Science Liaison

Contact Nancy Reyes

Maurizio Ferrante

Associate Director Medical Affairs Biotech and Primary Care

Contact Maurizio Ferrante

Paolo Ciocca

Responsabile divisione contabilità

Contact Paolo Ciocca

Stefania Scotti

Social Media and Digital Specialist

Contact Stefania Scotti

Roberta Montella

Medical Affairs Specialist

Contact Roberta Montella

View All Dompé Employees Contact All Dompé Employees
Dompé Details

Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and biotech products. Primary Care includes a broad spectrum of over-the-counter treatment solutions, prescription medications, supplements and medical devices. Our Biotech focuses on the development of treatments for rare diseases. The main therapeutic areas include pain relief, inflammation, ophthalmology, diabetes care, nutrition and oncology. In the pursuit of improving human health, our R&D strives to break through in unconventional places. This is what led us to Nerve Growth Factor (NGF), a Nobel Prize-winning discovery made in 1986. We leveraged 50 years of research to transform this discovery into a breakthrough treatment. Our human recombinant NGF, cenegermin, is the first treatment for a rare degenerative eye disease, neurotrophic keratitis. That deep appreciation of science keeps us committed to investigating neurotrophins. Our relentless pursuit in identifying new treatments for diseases allowed us to harness the potential of bioinformatics to accelerate the drug discovery process. The result is Exscalate, a structure-based virtual screening platform developed in-house and currently one of the most powerful supercomputing and artificial intelligence platforms for drug testing. We are focused on the road ahead. Our hunger to deliver what patients need from science keeps us focused on what matters. We embrace the challenge in science.

Dompé logo, Dompé contact details
Employees: 966
HQ: 392583831
Location: Milano, Lombardia, IT
Revenue: $270.1 million
Ophthalmology Prescription Pain Relief Rare Disease Medical Devices Biotechnology Bioinformatics Artificial Intelligence Biopharmaceuticals
Dompé Technologies
Email Providers

Outlook

Social Sharing

AddThis

Load Balancers

Nginx

Other

Microsoft Office 365

Hosting

Microsoft Azure Hosting

Online Video Platforms

YouTube

View All Technologies Used At Dompé
Similar companies to Dompé
Euticals

Contacting Dompé: Connect with Executives and Employees

Get in Touch with Dompé Executives and Employees

Connecting with Dompé's Executives and Workforce

Accessing Contact Information for Dompé Executives

Connecting with Dompé: Reach Out to Their Team

Discover How to Contact Dompé Executives and Staff

Looking to connect with Dompé executives or employees?

Seeking to Get in Touch with Dompé Executives or Staff?

Want to Reach Out to Dompé Executives or Team Members?

In Search of Contact Details for Dompé Professionals?

Connecting with Dompé: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z